Healthcare -
Biotechnology - NASDAQ - US
$ 3.345
1.36 %
$ 634 M
Market Cap
-7.78
P/E
ABUS - OTHER CURRENT ASSETS
Other Current Assets ABUS - Arbutus Biopharma Corporation
4.25 M
LAST VALUE
-30.87%
2 YEAR CAGR
5.96%
5 YEAR CAGR
12.60%
10 YEAR CAGR